UNICHEM LABORATORIES LTD
UNICHEMLAB · General/Diversified · NSE
₹385
Current Market Price
Fair Value (DCF)
₹496
Margin of Safety
+28.6%
Updated 7h ago
YieldIQ Score
56/100
Piotroski F-Score
5/9
Economic Moat
Narrow
Confidence
20%
ROE
—
Debt/Equity
0.21
WACC
11.1%
Market Cap
₹2,713 Cr
Quality & Valuation
Neutral model outputs — no recommendations.
ROCE
6.8%
Return on capital employed
EV / EBITDA
14.4×
Enterprise multiple
Debt / EBITDA
2.2×
Leverage vs earnings
Interest Coverage
8.5×
EBIT covers interest
Current Ratio
2.05×
Short-term liquidity
Asset Turnover
0.58×
Revenue per ₹ of assets
Revenue CAGR (3Y)
18.3%
3-year revenue growth
Revenue CAGR (5Y)
—
5-year revenue growth
DCF Scenario Analysis
vs CMP ₹385.4
Bear case
₹290.95
MoS -32.5%
Base case
₹495.67
MoS +22.2%
Bull case
₹627.53
MoS +38.6%
Ratio Trends
UNICHEMLAB · last 8 annual periods
ROE
5.6%
ROCE
10.3%
Operating Margin
—
Debt / Equity
0.19×
PE
25.6×
EV / EBITDA
—
Historical Financials
UNICHEMLAB · Annual, last 5 years· amounts in ₹Cr unless noted
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 | CAGR |
|---|---|---|---|---|---|---|
| Revenue | ₹1235 Cr | ₹1270 Cr | ₹402 Cr | ₹432 Cr | ₹2064 Cr | +13.7% |
| EBITDA | — | ₹118 Cr | ₹-46.7 Cr | ₹60.4 Cr | ₹300 Cr | +26.2% |
| EBIT | ₹56.9 Cr | ₹64.0 Cr | ₹-41.6 Cr | ₹-121 Cr | — | — |
| PAT | ₹34.3 Cr | ₹71.5 Cr | ₹-44.3 Cr | ₹-129 Cr | ₹138 Cr | +41.5% |
| EPS (diluted) | ₹4.88 | ₹10.14 | ₹-6.28 | ₹-18.36 | — | — |
| CFO | ₹33.1 Cr | ₹-260 Cr | ₹-85.1 Cr | ₹16.7 Cr | ₹-7.0 Cr | — |
| CapEx | — | — | — | — | ₹-137 Cr | — |
| FCF | — | — | — | — | ₹-144 Cr | — |
| Total Assets | — | ₹3319 Cr | ₹3193 Cr | ₹3169 Cr | ₹3569 Cr | +1.8% |
| Total Debt | — | — | ₹234 Cr | ₹181 Cr | ₹460 Cr | +18.4% |
| Shareholders' Equity | — | — | ₹2435 Cr | ₹2362 Cr | ₹2451 Cr | +0.2% |
CAGR computed across the visible window. Signs reverse if start value is zero or negative.
Peer Comparison
UNICHEMLAB vs 5 closest peers by market-cap band
| Peer | MoS | Score | Verdict | ROE | PE |
|---|---|---|---|---|---|
| SOLARA SOLARA | — | — | Pending | 0.0% | — |
| HIKAL HIKAL | — | — | Pending | 7.2% | — |
| MOREPENLAB MOREPENLAB | — | — | Pending | 9.9% | — |
| IOLCP IOLCP | — | — | Pending | 6.0% | — |
| BLISSGVS BLISS GVS PHARMA LTD | -46.4% | 22 | Overvalued | 7.7% | — |
Click a ticker to view its fair-value analysis.
Dividend History
No dividend events recorded for UNICHEMLAB in the last 10 years.
AI Analysis Summary
Model-generated description of metrics. Not investment advice. UNICHEM LABORATORIES LTD (UNICHEMLAB.NS) trades at 385.40 vs a model fair value of 495.67, a gap of 28.6%. Piotroski F-score: 5/9. Moat l...
Read full AI analysis →Reverse DCF
Market-implied growth
What FCF growth is priced in →
Risk Analysis
Volatility & drawdown
Risk profile of UNICHEMLAB →
DuPont
ROE decomposition
Why ROE is what it is →
Technicals
RSI, MACD, MAs
Reference indicators →
News & Filings
Recent activity
BSE filings + news for UNICHEMLAB →
Compare
Head-to-head with peers
Compare UNICHEMLAB side by side →
Run Full Interactive Analysis
Interactive DCF sliders, sensitivity heatmap, peer comparison, and more.
Analyse UNICHEMLABNow →Model estimates using publicly available data. Not investment advice. YieldIQ is not registered with SEBI as an investment adviser or research analyst. Past performance does not guarantee future results.